93 related articles for article (PubMed ID: 36181289)
1.
Tang W; Wang H; Wang Y; Wang X
Onco Targets Ther; 2018; 11():1-8. PubMed ID: 29302191
[TBL] [Abstract][Full Text] [Related]
2. Gene polymorphism and prediction of toxicity to platinum-based chemotherapy in patients with gynecologic cancer.
Huang X; Li J; Pang X; Zhu J; Pan J; Li Y; Tang J
Clin Transl Sci; 2023 Dec; 16(12):2519-2529. PubMed ID: 38013655
[TBL] [Abstract][Full Text] [Related]
3. Functional characterization of a novel transcript of ERCC1 in chemotherapy resistance of ovarian cancer.
Liu J; Zhang L; Mao P; Jiang G; Liu L; Wang J; Yang W; Owusu L; Li W
Oncotarget; 2017 Oct; 8(49):85759-85771. PubMed ID: 29156754
[TBL] [Abstract][Full Text] [Related]
4. ATR inhibition overcomes platinum tolerance associated with ERCC1- and p53-deficiency by inducing replication catastrophe.
Heyza JR; Ekinci E; Lindquist J; Lei W; Yunker C; Vinothkumar V; Rowbotham R; Polin L; Snider NG; Van Buren E; Watza D; Back JB; Chen W; Mamdani H; Schwartz AG; Turchi JJ; Bepler G; Patrick SM
NAR Cancer; 2023 Mar; 5(1):zcac045. PubMed ID: 36644397
[TBL] [Abstract][Full Text] [Related]
5. Genetic Variations and Cisplatin Nephrotoxicity: A Systematic Review.
Zazuli Z; Vijverberg S; Slob E; Liu G; Carleton B; Veltman J; Baas P; Masereeuw R; Maitland-van der Zee AH
Front Pharmacol; 2018; 9():1111. PubMed ID: 30319427
[No Abstract] [Full Text] [Related]
6. Genetic polymorphisms as potential pharmacogenetic biomarkers for platinum-based chemotherapy in non-small cell lung cancer.
Sito H; Tan SC
Mol Biol Rep; 2024 Jan; 51(1):102. PubMed ID: 38217759
[TBL] [Abstract][Full Text] [Related]
7.
Deng XD; Ke JL; Chen TY; Gao Q; Zhao ZL; Zhang W; Liu H; Xiang ML; Wang LZ; Ma Y; Liu Y
Front Neurol; 2022; 13():998428. PubMed ID: 36712419
[TBL] [Abstract][Full Text] [Related]
8. High levels of unfolded protein response component CHAC1 associates with cancer progression signatures in malignant breast cancer tissues.
Mehta V; Suman P; Chander H
Clin Transl Oncol; 2022 Dec; 24(12):2351-2365. PubMed ID: 35930144
[TBL] [Abstract][Full Text] [Related]
9. The association between the ERCC1/2 polymorphisms and the clinical outcomes of the platinum-based chemotherapy in non-small cell lung cancer (NSCLC): a systematic review and meta-analysis.
Yang Y; Xian L
Tumour Biol; 2014 Apr; 35(4):2905-21. PubMed ID: 24338713
[TBL] [Abstract][Full Text] [Related]
10. Pharmacogenetics of platinum-based chemotherapy in non-small cell lung cancer: predictive validity of polymorphisms of ERCC1.
Hamilton G; Rath B
Expert Opin Drug Metab Toxicol; 2018 Jan; 14(1):17-24. PubMed ID: 29226731
[TBL] [Abstract][Full Text] [Related]
11. A miR-15a related polymorphism affects NSCLC prognosis via altering ERCC1 repair to platinum-based chemotherapy.
Xue P; Zhang G; Zhang H; Cui S; Zhang L; Yu T; Xiao M; Li L; Lu X
J Cell Mol Med; 2022 Nov; 26(21):5439-5451. PubMed ID: 36181289
[TBL] [Abstract][Full Text] [Related]
12. Polymorphisms in ERCC1 gene could predict clinical outcome of platinum-based chemotherapy for non-small cell lung cancer patients.
Zhao X; Zhang Z; Yuan Y; Yuan X
Tumour Biol; 2014 Aug; 35(8):8335-41. PubMed ID: 24859833
[TBL] [Abstract][Full Text] [Related]
13. Rs3212986 polymorphism, a possible biomarker to predict smoking-related lung cancer, alters DNA repair capacity via regulating ERCC1 expression.
Yu T; Xue P; Cui S; Zhang L; Zhang G; Xiao M; Zheng X; Zhang Q; Cai Y; Jin C; Yang J; Wu S; Lu X
Cancer Med; 2018 Dec; 7(12):6317-6330. PubMed ID: 30453383
[TBL] [Abstract][Full Text] [Related]
14. Role of ERCC1 variants in response to chemotherapy and clinical outcome of advanced non-small cell lung cancer.
Huang SJ; Wang YF; Jin ZY; Sun JY; Guo ZL
Tumour Biol; 2014 May; 35(5):4023-9. PubMed ID: 24370899
[TBL] [Abstract][Full Text] [Related]
15. Association of ERCC1-C118T and -C8092A polymorphisms with lung cancer risk and survival of advanced-stage non-small cell lung cancer patients receiving platinum-based chemotherapy: a pooled analysis based on 39 reports.
Xu TP; Shen H; Liu LX; Shu YQ
Gene; 2013 Sep; 526(2):265-74. PubMed ID: 23727606
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
